首页> 外文期刊>Child and adolescent psychiatric clinics of North America >Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents.
【24h】

Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents.

机译:识别和监测儿童和青少年的第二代抗精神病药的不良事件。

获取原文
获取原文并翻译 | 示例
           

摘要

Although second-generation antipsychotics (SGAs) are used increasingly in children and adolescents, data on the effectiveness and safety in pediatric populations are still sparse. Much of the safety information is derived from studies conducted in adults. This derivation is problematic because children and adolescents are exposed to SGAs during a phase of unparalleled physical and psychologic development that can affect pharmacokinetic and pharmacodynamic drug actions, efficacy, and side-effect patterns. This article presents an overview of SGA-related side effects in children and adolescents and strategies to monitor health outcomes effectively in youngsters receiving SGAs.
机译:尽管第二代抗精神病药(SGA)在儿童和青少年中的使用越来越多,但有关儿童人群的有效性和安全性的数据仍然很少。许多安全信息来自成年人的研究。这种推导是有问题的,因为儿童和青少年在无与伦比的身体和心理发展阶段会接触到SGA,这可能会影响药代动力学和药效学药物的作用,功效和副作用模式。本文概述了儿童和青少年中SGA相关的副作用,以及有效监测接受SGA的年轻人健康状况的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号